
- Telehealth Visits
- Insurance plan information

Bradley Ekstrand, MD, PhD
Medical Oncology (Genitourinary Cancer) • Hematology and Medical Oncology (Lymphoma)- Telehealth Visits
- Insurance plan information



Bradley Ekstrand, MD, PhD
Medical Oncology (Genitourinary Cancer) • Hematology and Medical Oncology (Lymphoma)- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Bradley Ekstrand is a genitourinary oncologist who has particular interest and expertise in treating patients with lymphoma and genitourinary cancers. His background in the molecular biology of cancer gives him a unique perspective, combining a scientist's view of disease with a doctor's expertise, to bring the best care to patients with cancer.
Ekstrand earned his medical degree from Yale School of Medicine, where he also completed a doctorate in cancer biology. During his doctoral studies, he worked in the lab of acclaimed cancer genetics researcher Dr. Eric Fearon, where he focused on tumor suppressor genes. He completed a residency in internal medicine at Mount Sinai Medical Center and a fellowship in medical oncology at Stanford University School of Medicine. During his fellowship, he worked extensively in lymphoma with Drs. Sandra Horning and Gilbert Chu.
Ekstrand is a member of the American Society of Clinical Oncology and Association of Northern California Oncologists, where he serves as vice president. Through his work with these organizations, he advocates for high-quality cancer care for all patients.
A native of Boulder, Colorado, Ekstrand enjoys outdoor recreation, particularly alpine skiing, swimming and long-distance running. Outside of work, he devotes most of his time to family activities with his wife and three children. An avid sports fan, he follows Stanford athletics, European soccer leagues and the Denver Broncos.
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
Fellowship
- Medical Oncology, Stanford University School of Medicine
Residency
- Internal Medicine, Icahn School of Medicine at Mount Sinai
Internship
- Internal Medicine, Icahn School of Medicine at Mount Sinai
Degree
- MD, Yale University School of Medicine
My expertise
Specialties
- Genitourinary Medical Oncology
- Hematology and Medical Oncology (Lymphoma)
Conditions
- Testicular Cancer
- Localized Prostate Cancer
- Prostate Cancer
- Kidney Cancer
- Bladder Cancer
- Cancer
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221245%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221245%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Showing 1-6 of 111 reviews
- July 14, 20264.8 out of 5 Stars
I was very impressed with the doctor. He asked me very important questions that I never heard before about my health in the past and now.
- July 10, 20265 out of 5 Stars
I have been very pleased with the care provided by Dr. Ekstrand and the nursing staff.
- July 2, 20264.8 out of 5 Stars
Patient attentive clear caring knowledgeable
- June 29, 20265 out of 5 Stars
Listens to my issues addressed and provided excellent responses and other useful information.
- June 26, 20265 out of 5 Stars
Always well above any of my other health care providers. UC SF is wonderful!
- June 25, 20265 out of 5 Stars
It is so refreshing to have a doctor who listens, taking your concerns seriously in order to make informed decisions - thank you Dr. Ekstrand for being that kind of doctor.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.